Asia Pacific Foot And Ankle Devices Market Report

To learn more about this report, Download Free Sample Report

Asia Pacific Foot and Ankle Devices Market Size

As per the research report, the size of the Asia Pacific Foot and Ankle Devices market is valued at USD 1.48 billion in 2025 and is projected to reach USD 3.01 billion by 2034 from USD 1.60 billion in 2026, at a CAGR of 8.2% during the forecast period from 2026 to 2034.

The Asia-pacific foot and ankle devices market encompasses a comprehensive array of orthopedic implants, external fixation systems, and supportive bracing designed to address trauma, degenerative conditions, and sports-related injuries in the lower extremities. According to the World Health Organization, the Western Pacific Region accounted for 25% of global road traffic deaths in 2021, while the South-East Asia Region accounted for 28%, creating a substantial burden of lower limb injuries requiring orthopedic intervention. This epidemiological burden directly fuels the demand for internal fixation hardware, such as plates, screws, and intramedullary nails, across developing nations. According to the International Diabetes Federation, the Western Pacific region had approximately 215 million adults living with diabetes in 2024, creating a vast patient population susceptible to neuropathic ulcers and deformities that necessitate specialized offloading devices and reconstructive interventions. These clinical realities anchor the market structure by ensuring consistent procedural volumes in both public and private healthcare sectors. The industry is further characterized by rapid technological adoption in mature markets like Japan and Australia, where minimally invasive techniques are becoming standard. According to the Japanese Orthopaedic Association, data indicates a growing adoption of advanced foot and ankle surgical techniques, reflecting a shift toward advanced surgical care. This evolution ensures that the Asia-pacific foot and ankle devices market remains dynamic, balancing the need for affordable trauma solutions with the rising expectation for premium reconstructive options in increasingly sophisticated healthcare ecosystems.

MARKET DRIVERS

Rapidly Aging Population and Degenerative Joint Diseases

The demographic shift toward an older population is propelling the Asia-pacific foot and ankle devices market expansion by escalating the prevalence of osteoarthritis and other degenerative joint conditions that require surgical intervention. According to the United Nations, the number of older people is increasing rapidly worldwide, with the global population aged 60 years and above projected to reach about 2.1 billion by 2050, creating a growing cohort susceptible to age-related musculoskeletal disorders. Osteoarthritis of the ankle and hindfoot is a primary indication for total ankle arthroplasty and fusion procedures, which rely heavily on specialized implants and instrumentation. The statistical correlation between aging and joint degradation directly translates into increased surgical volumes, as conservative treatments often fail to provide long-term relief for severe cases. Additionally, the rise in life expectancy means patients are more likely to seek active lifestyles well into their later years, driving demand for mobility-preserving solutions. According to the Australian Institute of Health and Welfare, 61% of Australians were living with at least one chronic condition in 2022, supporting continued demand for musculoskeletal and orthopedic healthcare among an aging population. This trend ensures a robust pipeline of patients seeking functional restoration. Consequently, the Asia-pacific foot and ankle devices market benefits from a structural driver where demographic inevitabilities sustain high utilization rates for both temporary support and permanent reconstructive implants.

Increasing Participation in Sports and Physical Activities

The growing culture of fitness and recreational sports across Asia-Pacific further favors the Asia-pacific foot and ankle devices market by generating a steady volume of acute trauma cases requiring device-assisted recovery. According to the World Health Organization, road traffic injuries remain a major source of trauma across Asia-Pacific, with the South-East Asia Region accounting for 28% of global road traffic deaths in 2021. This surge in physical activity leads to a higher incidence of ligament tears, stress fractures, and tendon injuries, which often necessitate surgical repair or external bracing. The statistical rise in sports-related injuries is evident as participation in recreational and competitive physical activity expands across urban populations in the region. Furthermore, the professionalization of sports in the region has raised expectations for a rapid return to play, driving demand for advanced minimally invasive techniques and high-performance supportive devices. According to the World Health Organization, physical inactivity remains a major global health concern, reinforcing the importance of physical activity and injury prevention strategies that support demand for rehabilitation and orthopedic care. Thus, the Asia-pacific foot and ankle devices market is propelled by lifestyle changes where active living creates a consistent demand for both acute care and preventive support solutions.

MARKET RESTRAINTS

High Out-of-Pocket Healthcare Expenditure

The substantial financial burden associated with orthopedic procedures and advanced devices hampers the Asia-pacific foot and ankle devices market by limiting access for a large portion of the population in emerging economies. According to the World Bank, out-of-pocket spending remains an important component of health financing across many low- and middle-income economies, increasing the financial burden associated with costly medical treatment. This economic barrier forces individuals to delay necessary treatments or opt for cheaper, less effective alternatives, leading to worsened clinical outcomes and reduced device utilization. The statistical disparity in affordability is evident, as healthcare costs remain a significant contributor to financial hardship in lower-income populations. Additionally, insurance coverage for elective foot and ankle procedures, such as bunion corrections or total ankle replacements, is often limited or excluded in basic health plans. These financial constraints restrict the adoption of premium devices and force providers to rely on lower-cost generic implants that may offer inferior longevity. Consequently, the Asia-pacific foot and ankle devices market faces a persistent headwind where economic barriers limit market penetration and slow the adoption of next-generation technologies in price-sensitive healthcare systems.

Shortage of Specialized Orthopedic Surgeons

The limited number of surgeons specifically trained in complex foot and ankle reconstruction inhibits the Asia-pacific foot and ankle devices market by restricting the volume of advanced procedures that can be performed effectively. According to the World Health Organization, health workforce shortages remain a major challenge across the South-East Asia Region, with substantial gaps in nurses and midwives reported in the region. This scarcity means that many general orthopedists perform foot and ankle procedures with varying levels of proficiency, which can lead to inconsistent outcomes and higher complication rates. The statistical gap in specialized training limits the adoption of advanced devices that require precise technical skills for optimal placement, such as total ankle replacements or complex deformity corrections. According to the World Health Organization, the South-East Asia Region had a shortage of approximately 1.96 million nurses and 16,000 midwives in 2021, demonstrating the broader health workforce constraints affecting healthcare delivery. Furthermore, the learning curve for new technologies, such as robotic-assisted surgery, is steep, requiring significant time and resource investment from hospitals. These human capital constraints hinder the widespread implementation of innovative devices. Thus, the Asia-pacific foot and ankle devices market must navigate a talent shortage that limits procedural capacity and slows the diffusion of advanced surgical technologies.

MARKET OPPORTUNITIES

Expansion of Medical Tourism in Key Hubs

The growing prominence of medical tourism in countries like Thailand, India, and Malaysia is a significant opportunity for the Asia-pacific foot and ankle devices market by attracting international patients seeking high-quality and affordable orthopedic care. According to the World Health Organization, medical tourism and cross-border healthcare can expand access to specialized treatment while supporting healthcare system development in destination countries. This influx of foreign patients drives demand for premium implants and advanced surgical technologies as international standards of care are expected. The statistical growth in international healthcare travel reflects the increasing importance of specialized hospitals and internationally accredited healthcare providers across Asia. Hospitals catering to medical tourists often invest in state-of-the-art operating rooms and stock the latest generation of foot and ankle implants to maintain their competitive edge. According to the Thailand Ministry of Public Health, Thailand continues to promote international healthcare services through its medical hub strategy, supporting the development of specialized healthcare facilities and services. This dynamic allows local markets to bypass domestic economic constraints by tapping into international payment streams. Consequently, the Asia-pacific foot and ankle devices market can leverage medical tourism to drive adoption of premium products and foster technological advancement in leading regional healthcare centers.

Adoption of Minimally Invasive Surgical Techniques

The increasing acceptance of and training in minimally invasive surgical techniques offer a substantial opportunity for the Asia-pacific foot and ankle devices market by driving demand for specialized instrumentation and smaller-profile implants. According to published orthopedic literature, minimally invasive foot and ankle procedures can reduce soft tissue disruption and support faster postoperative recovery compared with conventional approaches in appropriately selected patients. This shift in clinical practice requires specific devices, such as small-diameter anchors, suture buttons, and cannulated screws, that are designed for limited-access approaches. The statistical rise in procedure volumes creates a new revenue stream for manufacturers who can provide comprehensive kits tailored to minimally invasive protocols. Furthermore, private insurance providers are increasingly covering these procedures due to shorter hospital stays, which reduce overall costs. According to peer-reviewed orthopedic literature, minimally invasive techniques continue to expand across foot and ankle surgery as surgical instrumentation and surgeon experience improve. This educational momentum supports sustained device adoption. Thus, the Asia-pacific foot and ankle devices market can capitalize on this clinical trend by introducing innovative tools that facilitate precision and efficiency in modern surgical settings.

MARKET CHALLENGES

Regulatory Fragmentation and Approval Delays

The lack of harmonized regulatory frameworks across Asia-Pacific countries poses a formidable challenge to the Asia-pacific foot and ankle devices market by creating complex and time-consuming approval processes for new products. According to the International Medical Device Regulators Forum, medical device regulators continue to work toward greater convergence and harmonization of regulatory requirements, demonstrating the importance of reducing differences among national systems. For instance, regulatory pathways in China, Japan, Australia, and other Asia-Pacific markets require manufacturers to satisfy country-specific requirements for clinical evidence, registration, and post-market surveillance. This variability increases compliance costs and discourages smaller manufacturers from entering multiple markets simultaneously. The absence of a unified regional regulatory body similar to the European Medicines Agency means that companies must navigate a patchwork of rules, which slows down the availability of innovative devices. According to the International Medical Device Regulators Forum, international regulatory convergence can reduce duplication and improve the efficiency of medical device regulation. These administrative hurdles limit patient access to the latest technologies and reduce the competitiveness of the regional market. Consequently, the Asia-pacific foot and ankle devices market faces ongoing operational inefficiencies where regulatory fragmentation impedes timely product introduction and market expansion.

Counterfeit and Substandard Medical Devices

The prevalence of counterfeit and substandard medical devices challenges the Asia-pacific foot and ankle devices market by undermining patient safety and eroding trust in legitimate brands. According to the World Health Organization, approximately 1 in 10 medical products in low- and middle-income countries is estimated to be substandard or falsified, highlighting a substantial quality assurance challenge for healthcare systems. These illicit products often fail to meet quality standards, leading to higher risks of treatment failure and adverse outcomes. The statistical impact on brand reputation is significant, as patients and surgeons may become hesitant to adopt new technologies if safety concerns persist. Additionally, the presence of cheap counterfeits distorts pricing dynamics, making it difficult for legitimate manufacturers to compete on cost without compromising quality. According to the World Health Organization, substandard and falsified medical products are more likely to reach patients where access to quality products is constrained and regulatory and technical capacity is weak. These illicit activities create an uneven playing field and increase liability risks for reputable companies. Thus, the Asia-pacific foot and ankle devices market must contend with a shadow economy that threatens clinical outcomes and sustainable business practices.

REPORT COVERAGE

SEGMENTAL ANALYSIS

By Products Insights

The orthopedic implants and devices segment accounted for the major share of the Asia-pacific market in 2025. The dominance of orthopedic implants and devices segment in the regional market is driven by their critical role in surgical reconstruction for severe trauma, arthritis, and complex deformities and the exceptionally high incidence of road traffic accidents and occupational injuries across the Asia-Pacific region, which generate a continuous demand for internal fixation. According to the World Health Organization, the Western Pacific Region accounted for 25% of global road traffic deaths in 2021, while the South-East Asia Region accounted for 28%, creating a substantial trauma burden requiring orthopedic stabilization. This epidemiological reality creates a non-discretionary demand for trauma implants that cannot be substituted by conservative therapies. The statistical volume of trauma surgeries directly correlates with implant consumption, as each complex fracture typically requires multiple components for stable reconstruction. Furthermore, public health systems in major nations like China and India prioritize trauma care funding, ensuring consistent procurement volumes despite economic fluctuations. According to published market data, orthopedic implants and devices represented approximately 47% of the Asia-Pacific foot and ankle devices market in the latest available regional segmentation, confirming their leading position. This reliance on surgical stabilization for acute injuries cements the leading status of implants. Consequently, the Asia-pacific foot and ankle devices market depends on this segment for baseline revenue stability driven by urgent clinical needs rather than elective preferences.

However, the bracing and supporting devices segment is estimated to showcase a CAGR of 8.1% over the forecast period owing to the preventive care trends and cost-containment pressures and a systemic shift toward conservative management strategies aimed at reducing surgical burden and healthcare costs in emerging economies. According to the World Bank, healthcare expenditure as a percentage of GDP remains constrained in many Asia-Pacific nations, prompting payers to favor non-operative treatments for mild to moderate conditions. Braces and supports offer a cost-effective alternative to surgery for issues like chronic instability, plantar fasciitis, and early-stage deformities. The statistical preference for low-cost interventions is evident as public health programs increasingly include orthotic devices in essential benefit packages to prevent disease progression. Furthermore, sports medicine awareness is rising, leading athletes and recreational users to adopt prophylactic bracing to avoid injury. According to published industry data, bracing and supporting devices are among the fastest expanding product categories in the regional market, supporting their position as a high-growth segment. This behavioral change expands the market beyond treatment to prevention. Consequently, the Asia-pacific foot and ankle devices market sees bracing as a high-growth avenue driven by economic pragmatism and evolving health consciousness.

By Cause Of Injury Insights

The trauma segment held the major share of the Asia-pacific foot and ankle devices market in 2025. The dominance of trauma segment in this regional market is attributed to pervasive safety challenges and high rates of accidental injuries and persistently high road traffic accident rates, which generate a continuous stream of complex fractures requiring surgical fixation. According to the World Health Organization, the South-East Asia Region recorded 330,222 road traffic deaths in 2021, equivalent to approximately 28% of global road traffic deaths. This safety deficit translates directly into high procedural volumes for trauma implants and external fixators. The statistical magnitude of this issue ensures that trauma remains the primary revenue driver regardless of economic cycles or elective surgery trends. Furthermore, rapid urbanization without commensurate infrastructure improvements exacerbates accident risks in growing metropolitan areas. According to the Asian Development Bank, road traffic injuries impose substantial economic costs on developing Asian economies through mortality, disability, healthcare expenditure, and productivity losses. This endemic problem guarantees steady demand for acute care devices. Consequently, the Asia-pacific foot and ankle devices market is anchored by trauma cases, which provide a resilient foundation for device manufacturers and distributors.

On the other end, the diabetes-related foot complications segment is estimated to record a prominent CAGR of 7.4% over the forecast period owing to the lifestyle transitions and improved screening and profound lifestyle transitions, including urbanization, dietary changes, and sedentary behavior, which accelerate metabolic disease onset. According to the International Diabetes Federation, diabetes affected more than 589 million adults worldwide in 2024, with the number projected to rise substantially by 2050, increasing the population at risk of diabetes-related foot complications. This epidemiological shift creates a burgeoning cohort of patients requiring lifelong foot surveillance and protective devices to prevent tissue breakdown. The statistical explosion in diabetes prevalence means that foot care is transitioning from a niche specialty to a mainstream public health priority. Furthermore, earlier diagnosis through improved screening programs identifies at-risk patients sooner, increasing the window for preventive device intervention. According to the International Diabetes Federation, the global number of adults living with diabetes is projected to reach approximately 853 million by 2050, reinforcing the long-term demand for diabetes-related foot care. This accelerating incidence rate ensures continued growth in demand for therapeutic footwear and offloading braces. Consequently, the Asia-pacific foot and ankle devices market sees diabetes as the most dynamic growth vector driven by societal changes that outpace other etiologies.

REPORT COVERAGE

REGIONAL ANALYSIS

China Foot And Ankle Devices Market Analysis

China held the largest share of the Asia-pacific foot and ankle devices market in 2025 and is likely to remain one of the strongest growth markets in the Asia-pacific foot and ankle devices market over the next few years, supported by its large aging population and expanding healthcare infrastructure. The nation serves as a major market for orthopedic devices due to its population scale and rising demand for the treatment of trauma and degenerative musculoskeletal conditions. According to the National Bureau of Statistics of China, the population aged 60 years and above reached 296.97 million at the end of 2023, representing 21.1% of the total population and creating substantial demand for degenerative joint treatments. This demographic weight supports a mature ecosystem of local and international device suppliers. Additionally, the basic medical insurance system provides coverage for essential orthopedic procedures, ensuring baseline demand stability. According to published market data, China is expected to be among the fastest-growing national markets in the Asia-pacific foot and ankle devices sector, with an expected CAGR of approximately 9.2% during the forecast period. Strong regulatory frameworks under the National Medical Products Administration also ensure product quality and safety. These factors collectively establish China as a leading market shaping regional trends and supply chain dynamics.

Japan Foot And Ankle Devices Market Analysis

Japan is likely to maintain a strong and technologically advanced position in the Asia-pacific foot and ankle devices market over the next few years, supported by its aging population, advanced healthcare infrastructure, and established orthopedic treatment capabilities. The country leads the region in the adoption of advanced technologies like total ankle replacements and minimally invasive techniques. According to the Ministry of Health, Labour and Welfare, Japan operates a universal health insurance system in which residents are covered through public health insurance programs. This payer mix supports access to orthopedic treatment and contributes to the continued adoption of medical technologies. Additionally, Japan’s stable regulatory environment attracts multinational companies to launch new products first in the region. According to published industry data, Japan accounted for approximately 29.2% of the Asia-pacific foot and ankle devices market in 2024, making it the largest country market in the region in the latest available country-level assessment. High life expectancy also drives degenerative condition treatments. These attributes make Japan a benchmark for quality and innovation in the regional landscape.

India Foot And Ankle Devices Market Analysis

India is likely to experience strong growth in the Asia-pacific foot and ankle devices market over the next few years, supported by its large population, rising healthcare accessibility, expanding medical tourism, and growing burden of diabetes and trauma. The country serves as a major hub for medical tourism and domestic orthopedic care. According to the Ministry of Health and Family Welfare, the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana has expanded access to publicly financed hospital care for eligible beneficiaries, strengthening the institutional healthcare base. This public sector scale drives volume for standard trauma and diabetic foot devices. Additionally, medical tourism attracts international patients seeking affordable orthopedic care, boosting demand for premium implants. According to published market data, India is among the fastest-growing national markets for foot and ankle devices in Asia-Pacific, supported by expanding private healthcare capacity and increasing access to advanced orthopedic treatment. Rising diabetes prevalence also fuels preventive care demand. These dynamics position India as a critical growth engine with unique cross-border market characteristics.

South Korea Foot And Ankle Devices Market Analysis

South Korea is likely to maintain a sophisticated and technology-driven position in the Asia-pacific foot and ankle devices market over the next few years, supported by high healthcare coverage, advanced medical infrastructure, and rapid adoption of innovative orthopedic technologies. The country leads in the adoption of advanced technologies and minimally invasive techniques. According to the National Health Insurance Service, South Korea's national health insurance system covered approximately 97% of the population through employee and self-employed insurance programs and medical aid arrangements in 2024. This payer mix supports access to orthopedic treatment and facilitates the uptake of innovative devices. Additionally, South Korea’s stable regulatory environment attracts multinational companies to launch new products first in the region. According to published industry data, South Korea remains one of the established markets for foot and ankle devices in Asia-Pacific, supported by advanced healthcare infrastructure and medical technology capabilities. High life expectancy also drives degenerative condition treatments. These attributes make South Korea a benchmark for quality and innovation in the regional landscape.

Australia Foot And Ankle Devices Market Analysis

Australia is likely to maintain a stable and premium position in the Asia-pacific foot and ankle devices market over the next few years, supported by high healthcare standards, chronic disease prevalence, and established access to orthopedic services. The country has a well-established healthcare system with strong coverage for orthopedic procedures. According to the Australian Institute of Health and Welfare, around 61% of Australians were living with at least one chronic condition in 2022, supporting continued demand for long-term healthcare and musculoskeletal management. This clinical burden supports a robust market for both trauma and elective devices. Additionally, the high prevalence of sports injuries drives demand for advanced bracing and supportive devices. According to the Australian Government Department of Health and Aged Care, private health insurance clinical categories include bone, joint, and muscle services as well as joint reconstruction and joint replacement services, supporting access to orthopedic treatment through private health coverage. Strong regulatory standards also ensure product safety and quality. These factors ensure Australia remains a key market for high-value devices.

COMPETITIVE LANDSCAPE

The competition in the Asia-pacific Foot And Ankle Devices Market is characterized by intense rivalry among established multinational corporations and specialized niche players who compete on technological superiority and clinical evidence. Large entities leverage their broad product portfolios and global distribution networks to dominate hospital accounts while smaller firms focus on innovative solutions for specific indications such as sports injuries or deformities. The barrier to entry is high due to stringent regulatory requirements and the need for extensive clinical data to prove safety and efficacy. Competitive intensity is driven by the rapid pace of technological advancement including robotics and 3D printing which forces continuous investment in research and development. Price competition exists but is secondary to product performance and surgeon preference which are critical for adoption. Regulatory compliance and reimbursement policies further shape competitive dynamics by influencing market access and profitability. This environment requires participants to demonstrate clear clinical benefits and provide robust support services to maintain market share and drive growth in a sophisticated medical device sector.

KEY MARKET PLAYERS

The Top companies dominating the APAC Foot and Ankle Devices Market include

• Össur
• Acumed
• Extremity Medical, LLC
• Smith & Nephew plc
• Wright Medical Technology, Inc.
• Integra LifeSciences Holdings Corporation
• Tornier N.V.
• Zimmer Biomet Holdings, Inc.
• Stryker Corporation
• Arthrex, Inc.

Top Players in the Market

Stryker Corporation

Stryker Corporation maintains a robust presence in the Asia-pacific Foot And Ankle Devices Market through its comprehensive portfolio of trauma and reconstructive solutions. The company leverages advanced manufacturing technologies to produce high quality implants that support complex surgical procedures across the region. Recently Stryker expanded its educational programs for surgeons in China and India focusing on minimally invasive techniques and digital planning tools. This initiative enhances clinical proficiency and drives adoption of their premium implant systems. Their commitment to innovation strengthens relationships with orthopedic specialists who prioritize patient outcomes. By offering end to end solutions from diagnostics to rehabilitation Stryker ensures seamless care pathways. These strategic actions solidify their reputation as a leader in providing reliable and advanced foot and ankle care products in Asia-pacific.

Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings Inc plays a pivotal role in the Asia-pacific Foot And Ankle Devices Market by combining extensive global reach with specialized expertise in musculoskeletal health. The company offers a diverse range of implants including total ankle replacement systems designed for durability and biocompatibility. Recently Zimmer Biomet launched new porous metal technologies in Japan and Australia that enhance bone ingrowth and long term implant stability. This material innovation addresses common challenges such as loosening and revision surgeries. They also invest heavily in surgeon education programs to promote best practices in foot and ankle reconstruction. Through strategic partnerships with local distributors Zimmer Biomet improves access to advanced care. These efforts reinforce their competitive edge and drive adoption of their premium product lines in key Asian markets.

Arthrex Inc

Arthrex Inc contributes significantly to the Asia-pacific Foot And Ankle Devices Market through its focus on minimally invasive surgical techniques and sports medicine applications. The company specializes in arthroscopic instruments and soft tissue repair devices that facilitate faster recovery for patients. Recently Arthrex introduced next generation suture anchors specifically designed for foot and ankle ligament repairs in South Korea and Thailand. This product expansion targets the growing demand for outpatient procedures among active individuals in the region. They also collaborate with professional sports organizations to validate product performance in high stress environments. By prioritizing surgeon feedback and clinical evidence Arthrex builds strong brand loyalty. These actions enhance their market position by addressing specific needs of the sports medicine community and expanding their footprint in ambulatory surgical centers across Asia-pacific.

Top Strategies Used by Key Market Participants

Key players in the Asia-pacific Foot And Ankle Devices Market primarily employ product innovation strategies by developing advanced materials and digital surgical tools to improve clinical outcomes and differentiation. Companies invest heavily in research and development to create porous implants and robotic assistance systems that enhance precision and osseointegration. Another major strategy involves expanding into emerging markets where healthcare infrastructure is improving and demand for orthopedic care is rising due to aging populations. Manufacturers establish local production facilities or distribution partnerships to reduce costs and navigate regulatory requirements effectively. Additionally participants focus on surgeon education and training programs to build loyalty and ensure proper utilization of complex devices. Strategic acquisitions of smaller innovative firms allow large corporations to integrate new technologies quickly. These combined tactics enable companies to maintain leadership and capture growth in a competitive and evolving industry landscape.

MARKET SEGMENTATION

This research report on the Asia Pacific Foot and Ankle Devices Market has been segmented and sub-segmented into the following categories.

By Products

• Orthopedic Implants and Devices
• Prostheses
• Bracing
• Supporting Devices

By Cause of Injury

• Trauma
• Diabetes
• Neurological Disorders
• Osteoporosis
• Rheumatoid Arthritis
• Osteoarthritis
• Hammertoe
• Bunions

By Country

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC